Innovation Agency, the Academic Health Science Network for the North West Coast, 6 July 2019
- Evaluation of a trial of chemotherapy treatment (subcutaneous administration of trastuzumab) at home and subsequently in the workplace delivered by The Clatterbridge Cancer Centre NHS Foundation Trust.
- Economic analysis by the Royal College of Physicians over the course of 2017 estimated savings to the trust of £182 per treatment episode at home compared to in the hospital, resulting in total estimated savings of nearly £400,000. The research did not take into account NHS patient transport costs or missed appointments, meaning that total savings to the NHS are almost certainly higher.
